Israeli CBD company starts clinical trial of potential COVID-19 treatment

The 10-patient trial will take place at Rabin Medical Center Golda HaSharon Campus in Petah Tikva


chriss_ns / iStock / Getty Images Plus


Earlier this week we told you how researchers at Ichilov Hospital in Tel Aviv, Israel, are looking at whether or not CBD can slow down inflammation in severe cases of COVID-19.

Also in Israel, Stero Biotechs, a company focused on cannabidiol-formulation research and development, has announced a small-scale clinical trial of a CBD-enhanced steroid treatment for coronavirus patients.

The 10-patient trial will take place at Rabin Medical Center Golda HaSharon Campus in Petah Tikva. Patients hospitalized with COVID-19 infection will receive the treatment for a few weeks, with a subsequent follow-up period of the same length.

In a statement, Stero Biotechs founder and CEO David Bassa said: “We estimate that our CBD-based treatment can enhance the current treatment of those patients who are in life-threatening conditions. Hospitalized COVID-19 patients are mostly being treated with steroids and our study is planned to demonstrate the benefit of a combined solution with Steroid treatments. We are hopeful that this study will lead to faster benefit for the growing number of COVID-19 patients in Israel and around the world.”

Pending the success of this initial trial, Stero plans to scale up and expand to a multi-centre clinical trial with an additional 40 hospitalized COVID-19 patients.

Thanks for the tip

Have you read a recent study that sheds new light on the topic of cannabis? Are you a researcher working on a clinical trial? If so, send me a link and I might feature it in a future edition of CannCentral’s Research Roundup. Thanks!


  • David Leng May 17, 2020 07:12 AM

    wish your Clinical trials will be successful, I’m forward heard good new from your Hospital

Leave your opinion for the editor...We read everything!

Your email address will not be published. Required fields are marked *